SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
SGP

SpyGlass Pharma, Inc. (SGP)

NASDAQ: SGP · Real-Time Price · USD
Healthcare · Biotechnology
$31.47-$0.77 (-2.39%)
 
Market cap
$1.05B
Insider Score
Analyst consensus
Market Cap$1.05B+31.1%
Revenue (ttm)n/a
Net Income-$70.49M
EPS-$2.70
Shares Out33.46M
PE Ration/a
Forward PE-10.38
Dividendn/a
Ex-Dividend Daten/a
Volume11,301
Open$32.09
Previous Close$32.24
Day's Range$30.53 - $32.81
52-Week Range$17.06 - $39.92
Betan/a
AnalystsStrong Buy
Price Target$46.67(+48.29%)
Earnings DateNov 12, 2026
-2.39% (1D)
No price history available.

About SGP

SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was headquartered in 2019 and is based in Irvine, California.

Address
15326 Alton Parkway, Irvine, CA, 92618, United States
Market Cap
1.05 billion
Employees
88
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$144.80M

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

When insiders bought and sold

1 year · open-market trades only
Closing Price Purchase Sale
$16.16$28.22$40.29MarMayJulSepNov
1 Day
-2.39%
5 Days
-7.93%
1 Month
+27.93%
6 Months
+48.44%
1 Year
+31.12%

$SGP stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in SGP holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by SGP's directors and management

Net Shares Purchased by Insiders−10M−5M02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

SGP Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New SGP patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to SGP from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from SGP’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
62% of score
99
News & Sentiment
38% of score
62

News check: Q3 earnings report and investor conference participation signal active execution; valuation concerns temper enthusiasm but don't negate operational progress.

Recent Insider Activity

Buys
13
Sells
0
Buy Value
$144.80M
Distinct Buyers
12

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

DMDVAAM S&P Developed Markets High Dividend Value ETF1.71%
BBCVirtus Biotech Clinical Trials ETF1.40%
IVSXApplied Finance IVS International SMID ETF0.81%
SBIOALPS Medical Breakthroughs ETF0.73%
BYREPrincipal Real Estate Active Opportunities ETF0.27%
PQINPGIM Quant Solutions Strategic Alpha International Equity ETF0.22%
PXUSPrincipal International Adaptive Multi-Factor ETF0.11%
TNXTT. Rowe Price Innovation Leaders ETF0.09%
IWCiShares Micro-Cap ETF0.08%
DMRIDeltaShares S&P International Managed Risk ETF0.05%
JHMDJohn Hancock Investments - Multifactor Developed International ETF0.03%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.03%

Weight is the stock’s share of each fund’s holdings.